SCHEMBL17876243

SCHEMBL17876243

c1ccc(N2Cc3cc(-c4ccc5oc6ccccc6c5c4)ccc3-c3cc(-c4ccc5oc6ccccc6c5c4)ccc3C2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
PRKDC P78527 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
MMP8 P22894 4/20 0.35
MMP3 P08254 2/20 0.35
TSHR P16473 2/20 0.34
HCRTR1 O43613 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876247 0.96 NPC1 (0.36) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876260 0.95 PRKDC (0.39) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876248 0.95 PRKDC (0.39) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876301 0.95 MAPT (0.40) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876236 0.93 NPC1 (0.38) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876250 0.92 PRKDC (0.34) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876244 0.92 PRKDC (0.34) MAPTPRKDCNPC1RAB9AKDM4E
SCHEMBL17876242 0.92 ALOX5 (0.45) MAPTPRKDCKDM4EMEN1HPGD
SCHEMBL17876228 0.92 ALOX5 (0.45) MAPTPRKDCKDM4EMEN1HPGD
SCHEMBL17876300 0.91 NPC1 (0.39) MAPTPRKDCNPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885PRKDC 4858/4885NPC1 2673/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885PRKDC 4858/4885NPC1 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.